NMRA
Price
$0.82
Change
+$0.04 (+5.13%)
Updated
Jul 3 closing price
Capitalization
132.89M
37 days until earnings call
SNDX
Price
$9.00
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
774.43M
36 days until earnings call
Interact to see
Advertisement

NMRA vs SNDX

Header iconNMRA vs SNDX Comparison
Open Charts NMRA vs SNDXBanner chart's image
Neumora Therapeutics
Price$0.82
Change+$0.04 (+5.13%)
Volume$389.87K
Capitalization132.89M
Syndax Pharmaceuticals
Price$9.00
Change-$0.00 (-0.00%)
Volume$817.85K
Capitalization774.43M
NMRA vs SNDX Comparison Chart in %
Loading...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NMRA vs. SNDX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMRA is a Hold and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (NMRA: $0.82 vs. SNDX: $9.00)
Brand notoriety: NMRA and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NMRA: 36% vs. SNDX: 34%
Market capitalization -- NMRA: $132.89M vs. SNDX: $774.43M
NMRA [@Biotechnology] is valued at $132.89M. SNDX’s [@Biotechnology] market capitalization is $774.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NMRA’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • NMRA’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, NMRA is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NMRA’s TA Score shows that 4 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • NMRA’s TA Score: 4 bullish, 4 bearish.
  • SNDX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than NMRA.

Price Growth

NMRA (@Biotechnology) experienced а +2.78% price change this week, while SNDX (@Biotechnology) price change was -3.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NMRA is expected to report earnings on Aug 12, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($774M) has a higher market cap than NMRA($133M). SNDX YTD gains are higher at: -31.921 vs. NMRA (-92.249). NMRA has higher annual earnings (EBITDA): -273.7M vs. SNDX (-318.27M). SNDX has more cash in the bank: 516M vs. NMRA (249M). NMRA has less debt than SNDX: NMRA (938K) vs SNDX (1.84M). SNDX has higher revenues than NMRA: SNDX (43.7M) vs NMRA (0).
NMRASNDXNMRA / SNDX
Capitalization133M774M17%
EBITDA-273.7M-318.27M86%
Gain YTD-92.249-31.921289%
P/E RatioN/AN/A-
Revenue043.7M-
Total Cash249M516M48%
Total Debt938K1.84M51%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NMRASNDX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 20 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNRG0.04N/A
+11.38%
United Energy Corp.
JRONY54.081.90
+3.64%
Jeronimo Martins, SGPS, SA
EFIN43.00N/A
N/A
Eastern Michigan Financial Corp.
IGGRF12.33N/A
N/A
IG Group Holdings Plc.
OXBDF4.23N/A
N/A
Oxford Biomedica PLC

NMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMRA has been loosely correlated with NGNE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NMRA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMRA
1D Price
Change %
NMRA100%
+5.04%
NGNE - NMRA
38%
Loosely correlated
+4.69%
ABOS - NMRA
37%
Loosely correlated
+2.65%
AURA - NMRA
36%
Loosely correlated
+1.55%
SNDX - NMRA
35%
Loosely correlated
N/A
INZY - NMRA
34%
Loosely correlated
N/A
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with CGON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
N/A
CGON - SNDX
53%
Loosely correlated
+0.82%
REPL - SNDX
52%
Loosely correlated
-1.57%
IDYA - SNDX
52%
Loosely correlated
+0.82%
ETNB - SNDX
50%
Loosely correlated
+0.59%
RNA - SNDX
50%
Loosely correlated
-0.65%
More